Geode Capital Management’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$552K Buy
247,513
+25,381
+11% +$69.6K ﹤0.01% 3554
2025
Q4
$769K Buy
222,132
+37,978
+21% +$114K ﹤0.01% 3454
2025
Q3
$381K Buy
184,154
+867
+0.5% +$2.17K ﹤0.01% 3716
2025
Q2
$398K Buy
183,287
+30,674
+20% +$60.5K ﹤0.01% 3629
2025
Q1
$229K Buy
152,613
+53,049
+53% +$162K ﹤0.01% 3796
2024
Q4
$501K Buy
99,564
+450
+0.5% +$3.26K ﹤0.01% 3602
2024
Q3
$799K Buy
99,114
+22,881
+30% +$214K ﹤0.01% 3430
2024
Q2
$439K Buy
76,233
+5,442
+8% +$44.1K ﹤0.01% 3608
2024
Q1
$843K Buy
70,791
+2,015
+3% +$22K ﹤0.01% 3425
2023
Q4
$1.29M Buy
68,776
+12,736
+23% +$113K ﹤0.01% 3247
2023
Q3
$532K Buy
56,040
+4,390
+8% +$54.3K ﹤0.01% 3580
2023
Q2
$738K Hold
51,650
﹤0.01% 3472
2023
Q1
$796K Buy
51,650
+8,092
+19% +$131K ﹤0.01% 3446
2022
Q4
$584K Buy
43,558
+1,262
+3% +$15.8K ﹤0.01% 3592
2022
Q3
$579K Hold
42,296
﹤0.01% 3646
2022
Q2
$479K Buy
42,296
+269
+0.6% +$2.94K ﹤0.01% 3788
2022
Q1
$561K Buy
42,027
+1,082
+3% +$15.6K ﹤0.01% 3878
2021
Q4
$719K Hold
40,945
﹤0.01% 3868
2021
Q3
$1.3M Buy
40,945
+2,376
+6% +$137K ﹤0.01% 3551
2021
Q2
$3.3M Buy
38,569
+10,986
+40% +$508K ﹤0.01% 3116
2021
Q1
$769K Buy
+27,583
New +$590K ﹤0.01% 3663

Other funds holding ANVS

Geode Capital Management's ANVS Position: Q1 2026 in Review

Geode Capital Management increased its Annovis Bio (ANVS) stake by 11% in Q1 2026, buying an estimated $69.6K and bringing the position to 247,513 shares worth $552K. The position accounts for ﹤0.01% of the portfolio, ranked #3554.

Geode Capital Management first reported a position in ANVS in Q1 2021 and has held it in 21 quarters since. The position peaked at $3.3M in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Geode Capital Management held 247,513 shares of Annovis Bio worth $552K as of Q1 2026.
  • Geode Capital Management bought 25,381 Annovis Bio shares in Q1 2026, an estimated $69.6K.
  • Annovis Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3554 holding.
  • Geode Capital Management first reported a position in Annovis Bio in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Annovis Bio position peaked at $3.3M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.